Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)

Historical Holders from Q2 2025 to Q4 2025

Symbol
CAI on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
277,487,877
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
113,389,372
Holdings value
$3,407,348,453
% of all portfolios
0%
Number of holders
137
Number of buys
95
Number of sells
50
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HALBERT DAVID D 44% $4,773,918,633 124,906,296 David D. Halbert 30 Jun 2025
J H Whitney VI L P 7.3% $774,207,825 20,256,615 J H Whitney VI LP 30 Jun 2025
RIVERVIEW GROUP LLC 1.3% 3,583,100 Millennium Management LLC 17 Jun 2025
As of 30 Sep 2025 Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 113,389,372 shares of 277,487,877 outstanding shares and own 41% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) own 37% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
Sixth Street Partners Management Company, L.P. 8.8% $737,658,320 24,385,399 0%
COATUE MANAGEMENT LLC 3.7% $306,801,490 10,142,198 0%
FMR LLC 3.5% $291,411,398 9,633,435 +12%
T. Rowe Price Investment Management, Inc. 2.9% $242,780,000 8,025,759 +9.9%
BRAIDWELL LP 2.6% $221,313,296 7,316,142 0%
PRICE T ROWE ASSOCIATES INC /MD/ 2.5% $209,474,000 6,924,745 +2.4%
Silver Lake Group, L.L.C. 1.9% $160,052,932 5,291,006 0%
NEUBERGER BERMAN GROUP LLC 1.6% $109,081,216 4,345,042 -30%
MILLENNIUM MANAGEMENT LLC 1.4% $119,126,678 3,938,072 +12%
PointState Capital LP 1.4% $117,482,560 3,883,721 +55%
ORBIMED ADVISORS LLC 1.1% $91,804,455 3,034,858 0%
AMERIPRISE FINANCIAL INC 0.61% $50,803,947 1,679,468 +3.3%
MORGAN STANLEY 0.55% $46,416,331 1,534,423 +91%
Clearbridge Investments, LLC 0.5% $41,782,213 1,381,230 +9.9%
CANADA PENSION PLAN INVESTMENT BOARD 0.48% $40,013,248 1,322,752 0%
Longaeva Partners L.P. 0.46% $38,900,532 1,285,968 -12%
ALLIANCEBERNSTEIN L.P. 0.43% $36,360,046 1,201,985 +28%
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.4% $33,764,778 1,116,191 +40%
Alyeska Investment Group, L.P. 0.4% $33,307,398 1,101,071 +193%
PERCEPTIVE ADVISORS LLC 0.4% $33,219,430 1,098,163 0%
Ghisallo Capital Management LLC 0.38% $31,706,931 1,048,163 0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.35% $29,382,734 971,330 -7.5%
JPMORGAN CHASE & CO 0.31% $25,957,677 858,105 -8.2%
LORD, ABBETT & CO. LLC 0.31% $25,713,000 850,000
Invesco Ltd. 0.29% $24,315,010 803,802 +59%

Institutional Holders of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 97 $2,617 -$624,383 $26.98 1
2025 Q3 113,389,372 $3,407,348,453 +$143,025,458 $30.25 137
2025 Q2 109,280,872 $2,919,429,193 +$2,917,131,238 $26.72 115